Last reviewed · How we verify
NCT05845658
Electrical Vestibular Nerve Stimulation (VeNS) as a Treatment for Anxiety: A Randomized Clinical Trial
NA trial testing Active VeNS in Anxiety in 60 participants. Completed in 10 June 2023.
10 June 2023
Quick facts
| Lead sponsor | Neurovalens Ltd. |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 25 October 2022 |
| Primary completion | 10 June 2023 |
| Estimated completion | 10 June 2023 |
| Sites | 1 location across India |
Drugs / interventions tested
- Active VeNS
- Sham VeNS
Conditions studied
- Anxiety — all drugs for Anxiety →
Sponsor
Neurovalens Ltd.
Who can join
Adults 22 to 80, any sex, with Anxiety. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The present study will be conducted at the Department of Physiology in collaboration with the Department of Psychiatry of R.D. Gardi Medical College, Ujjain, Madhya Pradesh. This double-blind randomized controlled trial will remotely enroll 60 subjects. Each participant will complete 20 stimulation sessions at a rate of 3-5 sessions per week. Each session will be 30 minutes on the day of usage. The study will be randomized with a 1:1 active; or sham control allocation. Endpoint analysis will be performed upon completion of the study.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05845658
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Anxiety
Currently open trials in the same condition.
- NCT07336238 — Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or · Phase 2 · recruiting
- NCT07522944 — AI-Guided Relaxation for Hemodialysis Anxiety · NA · recruiting
- NCT07466875 — Auricular Stimulation for Nicotine Withdrawal in Psychiatric Inpatients · NA · recruiting
- NCT07425951 — Building Cognitive Behavioural Skills With StoryBooks to Reduce Emotional Difficulties in Kindergarten Years · NA · recruiting
- NCT07473505 — Integrative Bilateral Cervical Sympathetic Blocks for Trauma-Related Symptoms in Special Operations Veterans: A Prospect · recruiting
Other Neurovalens Ltd. trials
Trials by the same sponsor.
- NCT06051864 — Electrical Vestibular Nerve Stimulation (VeNS) As a Treatment for Depression · NA · completed
- NCT05242367 — Electrical Vestibular Nerve Stimulation (VeNS) as a Treatment for PTSD · NA · completed
- NCT05907967 — Electrical Vestibular Stimulation (VeNS), Compared to a Sham Control For The Management Of Anxiety · NA · completed
- NCT04999709 — Electrical Vestibular Nerve Stimulation (VeNS) as a Treatment for Anxiety · NA · completed
- NCT04452981 — Electrical Vestibular Nerve Stimulation (VeNS) as a Treatment for Insomnia · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05845658 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Neurovalens Ltd.
- Last refreshed: 23 January 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05845658.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing